Oriola Oyj

Equities

OKDBV

FI0009014351

Pharmaceuticals

Market Closed - Nasdaq Helsinki 11:29:59 2024-04-23 am EDT 5-day change 1st Jan Change
1.06 EUR +0.57% Intraday chart for Oriola Oyj +1.15% -2.57%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Oriola Corporation Approves Dividend for the Financial Year Ending 31 December 2023, Payable on 11 April 2024 CI
Oriola Oyj Proposes Dividend for the Financial Year Which Ended 31 December 2023, Be Paid on 11 April 2024 CI
Transcript : Oriola Oyj, 2023 Earnings Call, Feb 16, 2024
Oriola Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Swedish Watchdog Starts Phase Two Inquiry into Oriola’s Dose Dispensing Unit Sale MT
Eva Nilsson Bågenholm Not to Stand for Re-Election as Board of Directors of Oriola Corporation CI
Oriola Plans EUR35 Million Investment in Resource Planning, Warehouse Systems Upgrade MT
Oriola Oyj Reports Impairment Charges for the Third Quarter of 2023 CI
Transcript : Oriola Oyj, Nine Months 2023 Earnings Call, Oct 31, 2023
Oriola Oyj Announces Dividend Policy CI
Oriola Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ApotekstjÄNst Sverige Ab signed an agreement to acquire Svensk Dos AB from Oriola Oyj. CI
Oriola Oyj(HLSE:OKDBV) dropped from S&P Global BMI Index CI
Orion and Oriola to Continue Partnership in Finland CI
Transcript : Oriola Oyj, H1 2023 Earnings Call, Jul 21, 2023
Oriola Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Oriola Oyj Announces Appointment of Niklas Lindholm, Ph. D. as Chief People Officer CI
Transcript : Oriola Oyj, Q1 2023 Earnings Call, Apr 27, 2023
Oriola Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Oriola Oyj Approves Payment of Dividend for the Financial Year Ending 31 December 2022, Payable on 14 April 2023 CI
Transcript : Oriola Oyj - Shareholder/Analyst Call
Oriola Oyj Announces Resignation of Elina Niemelä as Chief People Officer CI
Panu Routila, Juko-Juho Hakala and Lena Ridström Not to Stand for Re-Election as Board of Directors of Oriola Corporation CI
Transcript : Oriola Oyj, 2022 Earnings Call, Feb 16, 2023
Oriola Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Chart Oriola Oyj
More charts
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
1.054 EUR
Average target price
1.175 EUR
Spread / Average Target
+11.48%
Consensus
  1. Stock Market
  2. Equities
  3. OKDBV Stock
  4. News Oriola Oyj
  5. Finland's Oriola Names Chief Digital Officer